You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • Correction: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma

Article Text

Article menu

See original article:

Download PDFPDF

Correction
Correction: Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma

https://doi.org/10.1136/jitc-2021-004291corr1

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Liu J, Yang Y, Liu Z, et al. Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma. J ImmunoTher Cancer 2022;10:e004291.

    This article has been corrected since it was first published online. 'Shanghai Chest Hospital' has been added before 'Shanghai Jiao Tong University' in the affiliations of the relevant authors.